| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000022177 |
| Receipt No. | R000025399 |
| Scientific Title | The efficacy of the new strategy by enhanced abdominal CT for the patients with diverticula and hematochezia. |
| Date of disclosure of the study information | 2016/05/09 |
| Last modified on | 2021/05/06 (Ver. 7) |
| Basic information | ||
| Public title | The efficacy of the new strategy by enhanced abdominal CT for the patients with diverticula and hematochezia. | |
| Acronym | The efficacy of the new strategy for the patients with diverticula and hematochezia. | |
| Scientific Title | The efficacy of the new strategy by enhanced abdominal CT for the patients with diverticula and hematochezia. | |
| Scientific Title:Acronym | The efficacy of the new strategy for the patients with diverticula and hematochezia. | |
| Region |
|
|
| Condition | ||
| Condition | colonic diverticula | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Multicenter prospective study of the efficacy of the treatment strategy for the patients with colonic diverticula and hematochezia. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The rate of re-bleeding in the hospital |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | the group of urgent colonoscopy. If bleeding point is detected, endoscopic hemostasis is performed. There is no re-bleeding, from day 2 to day 4 ingestion is started. After day 5 the patient discharges hospital. | |
| Interventions/Control_2 | the group of conservative treatment. Without urgent colonoscopy, the patient is treated by intravenous hemostatic agent. There is no re-bleeding, from day 2 to day 4 ingestion is started. After day 5 the patient discharges hospital. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients with colonic diverticula by abdominal enhanced CT or colonoscopy, without extravazation.
The patients with hematochezia. The patients who agreed to this study. |
|||
| Key exclusion criteria | The patients with extravasation in abdominal enhanced CT.
The patients who were suspected the other disease, for example ischemic colitis and colorectal cancer |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Aichi medical university | ||||||
| Division name | Department of Gastroentelorogy | ||||||
| Zip code | 4801195 | ||||||
| Address | 1-1 yazako-karimata Nagakute-city Aichi prefecture | ||||||
| TEL | 0561-62-3311 | ||||||
| mebi@aichi-med-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Aichi medical university | ||||||
| Division name | Department of Gastroentelorogy | ||||||
| Zip code | 4801195 | ||||||
| Address | 1-1 yazako-karimata Nagakute-city Aichi prefecture Japan | ||||||
| TEL | 0561-62-3311 | ||||||
| Homepage URL | |||||||
| mebi@aichi-med-u.ac.jp | |||||||
| Sponsor | |
| Institute | Aichi medical university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Kasugai municipal hospital |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Aichi medical university |
| Address | 1-1 Yazakokarimata, Nagakute |
| Tel | 0561623311 |
| mebi@aichi-med-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi | ||||||
| Number of participants that the trial has enrolled | 30 | ||||||
| Results | finished | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | bloody stool | ||||||
| Participant flow | informed consent | ||||||
| Adverse events | none | ||||||
| Outcome measures | the usefulness of strategy | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025399 |